Logo

Mary Tedd Allen

Apr 28, 2017
Nanostring has appointed Mary Tedd Allen as its senior vice president of operations, effective May 1, 2017. Currently the firm's vice president of operations, Allen also served as Nanostring's VP of manufacturing. Prior to joining the company, she was director of research and programs at the Washington Technology Center, and before that she served as vice president of the advanced manufacturing and development group at Applied Biosystems. She holds a BA in chemistry from Mount Holyoke College and a PhD in chemistry from the University of Rochester.
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.